DJIA 17,776.12 -200.19 -1.11%
NASDAQ 4,900.89 -46.56 -0.94%
S&P 500 2,067.89 -18.35 -0.88%
market minute promo

Exelixis (NASDAQ: EXEL)



company name or ticker

Is Exelixis (EXEL) Stock a Solid Choice Right Now? - Tale of the Tape

Exelixis (EXEL) Highlighted As Weak On High Volume

18 Biotech Stocks These Wall Street Analysts Are Tracking

Exelixis (EXEL) In A Perilous Reversal

Why Exelixis, Inc. Shares Skyrocketed 57% in February

Exelixis shares soared in February as shareholders await two key catalysts.

Exelixis (EXEL) Shares March Higher, Can It Continue? - Tale of the Tape

Exelixis (EXEL) Shares March Higher, Can It Continue? - Tale of the Tape

XBI, FMI, EXEL, HALO: Large Inflows Detected at ETF

Looking Ahead at Exelixis, Inc.

The biotech faces two major value-creating events in 2015.

Exelixis' (EXEL) CEO Mike Morrissey on Q4 2014 Results - Earnings Call Transcript

Exelixis (EXEL) Q4 2014 Results - Earnings Call Webcast

See More Articles...